The combination treatment with the Hh/GLI inhibitor GANT61 and the mTOR inhibitor rapamycin strongly reduced the sphere formation and cell viability of pancreatic cancer cells, suggesting the possibility of controlling pancreatic CSCs by blocking both these signaling pathways. The gene discussed is MTOR; the disease is familial pancreatic carcinoma.